- Advisory services - Expert witness - Background - Independence - Contact # Andrew J. Hillman Dallas senior paralegal and healthcare compliance expert witness Press releases carried by - The Tennessean - Yahoo Finance - EIN Presswire Andrew Jonathan Hillman is a Dallas Senior Paralegal and Healthcare Compliance Expert Witness. He is also a healthcare operations advisor in Dallas, Texas. This site is the expert-witness and advisory profile. Andrew Hillman no longer owns or operates any healthcare facility, medical practice, or laboratory. He bills no insurer or payer. His only ongoing business activity is investing as a family office through Hillman Ventures. He now works with businesses as an independent advisor and serves as an expert witness through retaining counsel. He also works as a senior paralegal with a boutique law firm, performing his legal and investigative engagements, including personal injury and healthcare litigation support, under the supervision of its licensed attorneys. He is not an attorney and does not provide legal advice. Andrew Hillman with others. ## How Andrew Hillman advises businesses. Advisory work for companies building, buying, or operating healthcare businesses. Each service draws on three decades of having formed, licensed, and run these operations directly. Advisory only. Andrew Hillman does not own, operate, or hold a clinical or licensure interest in any client business, and bills no insurer or payer. ### Regulatory advising Guidance on healthcare and FDA regulatory pathways, licensure, and compliance structures, including the Stark Law, the Anti-Kickback Statute, HIPAA, CLIA, and state licensure as they arise in operations and transactions. ### Attorney selection Help identifying and vetting specialized healthcare, regulatory, and transactional counsel matched to a specific matter, and coordinating their work. Andrew Hillman is not a licensed attorney and does not provide legal advice. ### Due diligence Operational and regulatory diligence on healthcare acquisitions, partnerships, and investments, including licensure, billing, and compliance exposure. ### Site selection Evaluation of locations for surgical, laboratory, pharmacy, and clinical operations against regulatory, licensure, market, and operational criteria. ### Facility design Advisory on layout, workflow, and the physical and compliance requirements of licensed surgical, laboratory, and pharmacy facilities. ### Equipment negotiation Support sourcing clinical and laboratory equipment and negotiating purchase, lease, and service terms. ## The compliance and litigation-support practice. Andrew Hillman's primary focus, drawn from healthcare operations and compliance engagements and from expert-witness and senior-paralegal work in federal matters nationwide, conducted through retaining counsel. He is not a licensed attorney and provides operator and compliance support, not legal opinion. ### Regulatory governance and SOP drafting Policy lifecycle management, board reporting metrics, and internal controls implementation. ### Vendor and contract risk management Vendor audit playbooks, service level agreement reviews, and third-party risk logging. ### Data privacy and operational security State privacy laws including CCPA and CPRA, HIPAA, enterprise data-privacy workflows, and vendor data-use audits. ### Internal audit and investigations Triage management, document-retention playbooks, and internal compliance review, conducted under counsel. ### Litigation and defense support White-collar and regulatory defense support, evidentiary review, and subpoena compliance, under retaining counsel. ## Consulting expert or testifying expert. Separate from the advisory practice, Andrew Hillman is retained as an expert witness in either capacity. The role is fixed in writing at the outset, and the scope of any opinion is stated in the engagement agreement. He is not a licensed attorney. He offers operator testimony on healthcare business practice, drawn from having built and run these operations, not legal opinion. - Pre-filing case evaluation Early assessment of the healthcare operations and compliance issues in a matter, including whether an operator opinion is available on the facts. - Discovery and document analysis Review and analysis of operating records, contracts, policies, ownership documents, and billing records. Assistance framing document requests and deposition topics. - Expert report preparation Preparation of a written report stating the opinions offered, the facts and data considered, and the basis for each opinion. - Deposition and trial testimony Deposition testimony and testimony at hearing or trial, within the scope disclosed in the report. ## The operating record behind the opinions. Andrew Jonathan Hillman is a Dallas healthcare operator with three decades co-founding and running FDA-regulated surgical hospitals, ambulatory surgical centers, clinical laboratories, and pharmacy businesses. Since 2020 he has served as an expert witness on healthcare operations, hospital business practice, and federal regulatory matters, engaged through retaining counsel. His opinions rest on having built, licensed, staffed, and run these businesses. Where the operating record is incomplete on a given question, he states the limit rather than filling it with inference. Outside his engagements, Andrew Hillman values time with his family, his advisory work, and his senior paralegal work with a boutique law firm, under the supervision of its licensed attorneys. ### Ownership and licensure - Past owner and operator of a Class A retail pharmacy, a Class G administrative pharmacy, and a wholesale pharmacy distributor. - Past owner and operator of ambulatory surgical centers, acute care hospitals, and a rehabilitation hospital. - Past owner and operator of clinical and toxicology laboratories. - Past owner and operator of FDA-regulated medical device companies. ### Companies and facilities in the record A selection. The fuller CURRENT vs PAST list is on /ventures . Each entity below is documented in a primary public source. The filings, clearances, and registry records are indexed on the credentials and verification page . - Dynacq Healthcare, Inc. (NASDAQ: DYII), a public healthcare company taken private. SEC filings under CIK 890908 include a 2013 Form 10-K and a 2014 SC 14D-9. - Victory Medical Center facilities, including Plano, Craig Ranch in McKinney (CMS NPI 1164867198), and South Cross in San Antonio. The Victory hospitals were acquired by Nobilis Health Corp. (SEC EDGAR CIK 1409916), reported contemporaneously by Becker's Hospital Review, Becker's ASC, and GlobeNewswire. - Surgery Specialty Hospitals of America , Pasadena, Texas (CMS NPI 1891718789), the facility operated under Dynacq Healthcare. - Bone Solutions, Inc. , Southlake, Texas, an orthobiologics company with eight FDA 510(k) clearances, including K161568 and K192674. - United Toxicology (CMS NPI 1063707743), a toxicology laboratory. - Prestonwood Surgery Center (CMS NPI 1225225154) and Medical Edge Healthcare Group (CMS NPI 1063573541). - The Apothecary Shop pharmacies, formerly Over the Counter, and Digimed , both taken private. ### Featured white paper - The Architecture of Compliance: Federal and State Healthcare Law for the Practicing Physician . 2026. White paper. The False Claims Act, Anti-Kickback Statute, Stark Law, HIPAA, EKRA, and qui tam whistleblower exposure, and the operational infrastructure that turns statutory knowledge into a defensible compliance record. ### Authored and indexed publications ORCID iD 0009-0001-5396-321X . Wikidata Q139969699 . OpenAlex author record OpenAlex (A5139488776). ResearchGate Andrew-Hillman . Each item below carries a registered DOI and is indexed in OpenAIRE. Titles are listed as published. - Mesenchymal Stromal Cell-Derived Exosomes and Extracellular Vesicles Across Therapeutic Indications: A Structured Review of Published Preclinical and Early-Phase Clinical Study Designs, Administration Parameters, and Reported Outcomes . 2026. Structured review, CC BY 4.0, Zenodo. DOI 10.5281/zenodo.21209815. - Mesenchymal Stem Cell-Derived Extracellular Vesicles for Tissue Repair Across Multiple Body Systems: A Narrative Review . 2026. Narrative review, CC BY 4.0, Zenodo. DOI 10.5281/zenodo.23574345. - Author profile, Academia.edu . Additional papers, including one on the Targeted Osmotic Lysis platform. These publications are listed to document authorship and subject-matter familiarity. Nothing in them, and nothing on this site, is a claim of FDA approval, safety, or efficacy for any product or therapy. ## Current roles. Past companies on /ventures. Current work is below. Past companies are not repeated on this page. CURRENT Principal, Hillman Ventures. A Dallas biotech family office. Healthcare operations advisor and expert witness, retained through counsel. Not an attorney. PAST Past ownership and exited companies from the public record are listed on /ventures . ## How the work is conducted. - Current status. Andrew Hillman no longer owns or operates any healthcare facility, medical practice, or laboratory. He bills no insurer or payer. His only ongoing business activity is investing as a family office through Hillman Ventures. He provides independent advisory services to businesses and serves as an expert witness through retaining counsel. - Andrew Hillman provides impartial analysis based on documented evidence. He does not tailor an opinion to the retaining party. - Compensation is not contingent on the outcome of any matter, and no fee is tied to a verdict, an award, or a settlement. - Engagements are arranged through retaining counsel under a separate written agreement. - Scope, current professional status, and any potential conflicts are disclosed before work begins. - He is not a licensed attorney. He offers operator testimony on healthcare business practice, not legal opinion. - Where the record does not support an opinion, he says so. ## Inquire about an engagement. Counsel inquiries only. A conflicts check is run before any substantive discussion of a matter. Email is the fastest route. The link below opens a message pre-filled with the intake items listed here. Firm Firm name and the office handling the matter. Attorney contact Name, direct line, and email of retaining counsel. Jurisdiction Court, venue, and case number if filed. Case posture Pre-filing, discovery, expert designation, or trial. Parties All parties and affiliates, for the conflicts check. High-level issue The healthcare operations or compliance question at issue. Role sought Key deadlines Designation deadline, report deadline, discovery cutoff, and trial date. Direct email, contact@andrewjhillman.com . LinkedIn profile, Andrew Hillman X profile, @AndrewHillmanTX Wikidata OpenAlex Crunchbase Substack Andrew Hillman Dallas The Hillman Letter Andrew Hillman of Dallas, Texas is also known as Andrew Jonathan Hillman, Andrew J. Hillman, Andy Hillman, and A.J. Hillman. One person, one official network. Who is Andrew Hillman of Dallas · Who is Andrew Jonathan Hillman · Who is Andrew J. Hillman · Who is Andy Hillman · Who is A.J. Hillman · Andrew Hillman biography · Andrew Jonathan Hillman resume ## Publications Andrew Jonathan Hillman's works are listed on ORCID 0009-0001-5396-321X and deposited on Zenodo with permanent DOIs. - Wharton's Jelly MSC-Derived Exosomes in Spinal Disc Repair . Zenodo DOI 10.5281/zenodo.20978822 - Mesenchymal Stem Cell-Derived Exosomes from Wharton's Jelly: The Gold Standard for Safe, Compliant Regenerative Medicine . Zenodo DOI 10.5281/zenodo.20974697 - Mesenchymal Stem Cell-Derived Extracellular Vesicles for Tissue Repair Across Multiple Body Systems: A Narrative Review . Zenodo DOI 10.5281/zenodo.23574345 - The Biologics Paradigm: Wharton's Jelly Mesenchymal Exosomes as a Section 351(a) Drug vs. the Section 361 HCT/P pathway . Zenodo DOI 10.5281/zenodo.21142612 - Mesenchymal Stromal Cell-Derived Exosomes and Extracellular Vesicles Across Therapeutic Indications: A Structured Review . Zenodo DOI 10.5281/zenodo.21209815 - Mesenchymal Stem Cell-Derived Exosomes from Wharton's Jelly Umbilical Cord: Regulatory Classification Under FDA CBER Section 351(a) . Zenodo DOI 10.5281/zenodo.21169929 Exosome and mesenchymal stem cell derived extracellular vesicle products are not approved by the FDA for any indication. The work referenced here describes published scientific literature. It does not describe an available treatment. Expert witness page: Dallas Healthcare Compliance Expert Witness . ## Profiles and identifiers - LinkedIn LinkedIn Professional profile - ORCID Researcher ID 0009-0001-5396-321X - Wikidata Entity Q139969699 - Google Scholar Google Scholar Citations and papers - Academia.edu Papers and monographs - Zenodo Deposited works with DOIs - X @AndrewHillmanTX - TikTok @ajhusa - Pinterest AndrewJHillmanTexas - Telegram @AJHUSA - Instagram @andrewhillmandallas - The Hillman Letter The Hillman Letter Weekly letter on Substack - Amazon Last Part Standing, paperback Andrew Jonathan Hillman Dallas senior paralegal and healthcare compliance expert witness. Not an attorney. Expert witness page · Publications ## Profiles - LinkedIn - ORCID - Wikidata - Google Scholar - Academia.edu - X - TikTok - Pinterest - Telegram - Instagram - Book a meeting - The Hillman Letter ## Press - The Tennessean - Yahoo Finance - EIN Presswire ## Sites - Hub - Expert witness - Giving - Advisory - Hillman Ventures - Public record AJH Dallas - LinkedIn - Credentials and verification - Disclaimer - Privacy - Terms - Accessibility - Add as a preferred source on Google. - Professional biography - Who is Andrew Jonathan Hillman - Venture platform - Community & giving - Complete public record - Advisory services - andrewhillman.net Copyright 2026 Andrew Jonathan Hillman, Dallas, Texas. This site is a professional informational profile for retaining counsel. It is not legal, medical, or financial advice, and it is not an offer of legal representation. Andrew Hillman is not a licensed attorney and no attorney-client relationship is created by this site. No expert or consulting relationship is formed without a separate written engagement arranged through retaining counsel. Nothing on this site is a claim of FDA approval, safety, or efficacy for any product or therapy. Last updated August 29, 2026. Expert witness: Dallas Healthcare Compliance Expert Witness